These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8135483)

  • 1. A combined chemo-endocrine treatment with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma.
    Wada T; Houjou T; Kubo R; Yasutomi M; Kurita T
    Anticancer Res; 1993; 13(6B):2465-7. PubMed ID: 8135483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A combined chemo-endocrine therapy with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma].
    Wada T; Morikawa E; Yasutomi M; Takagi H; Aizawa M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1652-6. PubMed ID: 2230447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined chemoendocrine treatment with tegafur and tamoxifen for advanced renal cell carcinoma.
    Wada T; Nishiyama K; Maeda M; Hara S; Tanaka N; Yasutomi M; Kurita T
    Anticancer Res; 1995; 15(4):1581-4. PubMed ID: 7654050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A combined chemo-endocrine therapy of advanced renal cell carcinoma].
    Wada T; Yasutomi M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2294-8. PubMed ID: 3128617
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant chemotherapy with vinblastine, adriamycin and UFT (VAU) for renal cell carcinoma].
    Masuda F; Nakada J; Kondo I; Furuta N
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2143-6. PubMed ID: 1888185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
    Niijima T; Aso Y; Akaza H; Kameyama S; Koiso K; Kawabe K; Kawamura T; Isurugi K; Yokoyama M; Shoji F
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):109-14. PubMed ID: 3122664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers].
    Wada T; Matunami N; Houjou T; Morikawa E; Mori N; Nakano K; Aizawa M; Kurooka K; Kadota K; Yamato M
    Gan To Kagaku Ryoho; 1989 May; 16(5):2087-92. PubMed ID: 2525004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-cytokine therapy for advanced renal cell carcinoma: determination of the minimal effective dose.
    Hamada I; Kato M; Okada K
    Anticancer Res; 2002; 22(4):2429-36. PubMed ID: 12174939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
    Nakagami Y; Lin TT; Ito H; Hirasawa S; Tannawa K; Fujioka Y; Ogawa H; Tanaka K; Yamada N; Ishii Y
    Hinyokika Kiyo; 1987 Oct; 33(10):1728-32. PubMed ID: 3128071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of UFT in renal cell carcinoma].
    Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):325-30. PubMed ID: 3918508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].
    Yamaguchi S; Fukuda M; Ota T; Nakayama Y; Ogata H; Shimizu K; Nishikawa T; Adachi Y; Fukuma E
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1145-52. PubMed ID: 10431580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of UFT for the treatment of renal cell carcinoma.
    Masuda F; Mori Y; Nakada J
    Prog Clin Biol Res; 1989; 303():707-9. PubMed ID: 2506559
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs].
    Okumura S; Nishimura T; Yoshida K; Ohhara M; Hasegawa J; Hirasawa S; Hara M; Kawamura N; Kanamori S; Akimoto M
    Hinyokika Kiyo; 1984 Sep; 30(9):1167-71. PubMed ID: 6084420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy.
    Vis AN; van der Gaast A; van Rhijn BW; Catsburg TK; Schmidt C; Mickisch GH
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):342-5. PubMed ID: 11914915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience.
    Marx G; Taylor J; Goldstein D
    Intern Med J; 2005 Jan; 35(1):34-8. PubMed ID: 15667466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neocarzinostatin therapy of advanced renal cell carcinoma].
    Tari K; Satake I; Kojima S; Tsujii T; Yonese J
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH; Chen J; Wu CY; Cheng AL; Pu YS
    Anticancer Res; 2001; 21(1B):711-5. PubMed ID: 11299831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.